4.21 USD
↘ 1.95 (31.70%)LIVE (AS OF 11:09 AM EDT)
Artiva Biotherapeutics, Inc. Common Stock
ARTVNASDAQ • USD
Market: OPEN
ARTV is currently priced at $4.21. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest ARTV is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 26, 2026.
Open?$4.25
High?$6.47
Low?$4.02
Prev. Close?$6.16
Volume?5.0M
Avg. Volume?524.2K
VWAP?$4.22
Rel. Volume?9.59x
Bid / Ask
Bid?$3.88 × 100
Ask?$4.18 × 100
Spread?$0.30
Midpoint?$4.03
Valuation & Ratios
Market Cap?301.2M
Shares Out?48.9M
Float?13.6M
Float %?27.9%
P/E Ratio?N/A
P/B Ratio?0.87
EPS?-$1.86
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Themes
Employees
115
Market Cap
301.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-07-19
Address
5505 MOREHOUSE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 267-4467
SAN DIEGO, CA 92121
Phone: (858) 267-4467
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?15
Piotroski F-Score?0/9Weak
Altman Z-Score?7.35Safe
Confidence?41%Low
Short InterestSqueeze Risk
Short % of Float?20.08%Squeeze Risk
Short Interest?2.7M
Days to Cover?6.0
Free Float13.6M
Avg Daily Volume456.2K
Settlement Date2026-10-15
Financial Health
Current Ratio?24.16Strong
Quick Ratio?24.16Strong
Cash Ratio?20.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.87CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-26.1%WEAK▾
S&P7
ROA?-24.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-76910000
Enterprise Value?$-290855
Fundamentals ratios updated end of day